Picture of Baronsmead Second Venture Trust logo

BMD Baronsmead Second Venture Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall CapSucker Stock

REG - Baronsmead Second VT - Half-yearly Report

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240611:nRSK8783Ra&default-theme=true

RNS Number : 8783R  Baronsmead Second Venture Trust PLC  11 June 2024

 
Baronsmead Second Venture Trust plc

Half-yearly report for the six months ended 31 March 2024

The Directors of Baronsmead Second Venture Trust plc are pleased to announce
the unaudited half-yearly financial report for the six months to 31 March
2024. Copies of the half-yearly report can be obtained from the following
website: www.baronsmeadvcts.co.uk (http://www.baronsmeadvcts.co.uk/) .

Our investment objective

 * Baronsmead Second Venture Trust plc (the "Company") is a tax efficient listed
company which aims to achieve long-term positive investment returns for
private investors, including tax free dividends.

 

Investment policy(1)

 * To invest primarily in a diverse portfolio of UK growth businesses, whether
unquoted or traded on the Alternative Investment Market ("AIM").

 * Investments are made selectively across a range of sectors in companies that
have the potential to grow and enhance their value.

 

Dividend policy(2)

 * The Board will, where possible, seek to pay two dividends to shareholders in
each financial year, typically an interim dividend in September and a final
dividend following the Annual General Meeting in February/March.

 

 * The Board will use, as a guide, when setting the dividends for a financial
year, a sum representing 7 per cent. of the opening net asset value of that
financial year.

 

1. This is a summary of the Company's investment policy that is set out on
page 99 of the Company's Annual Report and Financial Statements for the year
ended 30 September 2023.

2. This is a summary of the Company's dividend policy that is set out on page
36 of the Company's Annual Report and Financial Statements for the year ended
30 September 2023.

 

Key elements of the business model

Access to an attractive, diverse portfolio

The Company gives shareholders access to a diverse portfolio of growth
businesses.

The Company will make investments in growth businesses, whether unquoted or
traded on AIM, which are substantially based in the UK in accordance with the
prevailing VCT legislation. Investments are made selectively across a range of
sectors.

 

The Manager's approach to investing

The Manager endeavours to select the best opportunities and applies a
distinctive selection criteria based on:

·      Primarily investing in parts of the economy which are
experiencing long-term structural growth.

·      Businesses that demonstrate, or have the potential for, market
leadership in their niche.

·      Management teams that can develop and deliver profitable and
sustainable growth.

·   Companies with the potential to become an attractive asset appealing to
a range of buyers at the appropriate time to sell.

In order to ensure a strong pipeline of opportunities, the Manager invests in
building deep sector knowledge and networks and undertakes significant
proactive marketing to interesting target companies in preferred sectors. This
approach generates a network of potentially suitable businesses with which the
Manager maintains a relationship ahead of possible investment opportunities.

 

The Manager as an influential shareholder

The Manager is an engaged and supportive shareholder (on behalf of the
Company) in both unquoted and significant quoted investments.

 

For unquoted investments, representatives of the Manager often join the
investee board.

The role of the Manager with investees is to ensure that strategy is clear,
the business plan can be implemented and that management resources are in
place to deliver profitable growth. The intention is to build on the business
model and grow the company into an attractive target which can be sold or
potentially floated in the medium term.

Financial highlights

329.7p Net Asset Value ("NAV") total return to shareholders for every 100.0p
invested at launch (January 2001).

NAV per share increased 3.8 per cent. to 57.7p before the deduction of
dividends in the six months to 31 March 2024.

£25.0mn raised in the period (before costs).

£7.3mn Investments made into four new and six follow-on opportunities during
the period. (Unquoted: £6.2mn, Quoted: £1.1mn).

Cash returned to shareholders

 

The table below shows the cash returned to shareholders that invested in
Baronsmead Second Venture Trust plc dependent on their subscription cost,
including the income tax available to be reclaimed on the subscription.

 

 Year subscribed          Cash invested  Income tax reclaim                      Cumulative dividends  Return on cash invested(#) (%)

                          (p)            (p)                 Net cash invested   paid(#)

                                                             (p)                  (p)
 2001 (January)           100.00         20.00               80.00               166.55                186.6
 2005 (March) - C Share*  100.00         40.00               60.00               121.12                161.1
 2010 (March)             103.09         30.93               72.16               118.25                144.7
 2012 (December)          117.40         35.22               82.18               100.25                115.4
 2014 (March)             112.40         33.72               78.68               80.25                 101.4
 2016 (February)          107.20         32.16               75.04               63.75                 89.5
 2017 (October)           97.48          29.24               68.24               43.75                 74.9
 2019 (February)          85.30          25.59               59.71               36.25                 72.5
 2019 (November)          78.90          23.67               55.23               28.75                 66.4
 2020 (January)           84.80          25.44               59.36               28.75                 63.9
 2020 (February)          82.50          24.75               57.75               25.25                 60.6
 2020 (March)             64.30          19.29               45.01               25.25                 69.3
 2020 (November)          77.90          23.37               54.53               22.25                 58.6
 2020 (December)          80.90          24.27               56.63               22.25                 57.5
 2021 (January)           84.40          25.32               59.08               22.25                 56.4
 2021 (February)          82.20          24.66               57.54               18.75                 52.8
 2021 (March)             84.90          25.47               59.43               18.75                 52.1
 2021 (December)          88.10          26.43               61.67               15.75                 47.9
 2022 (January)           87.10          26.13               60.97               15.75                 48.1
 2022 (March)             76.60          22.98               53.62               12.25                 46.0
 2023 (January)           68.19†         20.46               47.73               9.25                  43.6
 2023 (March)             65.72†         19.72               46.00               6.25                  39.5
 2023 (April)             62.96†         18.89               44.07               6.25                  39.9
 2024 (January)           61.05†         18.32               42.74               4.00                  36.6
 2024 (February)          60.63†         18.19               42.44               1.75                  32.9
 2024 (April)             60.67†         18.20               42.47               1.75                  32.9

 

The total return could be higher for those shareholders who were able to defer
a capital gain on subscription and the net sum invested may be less.

*   Dividends paid to C shareholders post conversion have been adjusted by
the conversion ratio (0.85642528).

#  Includes interim dividend of 1.75p per share payable 9 September 2024.

†  Average effective offer price. Shares were allotted pursuant to the 2023
& 2024 Offers at individual prices for each investor in accordance with
the allotment formula as set out in each Offers Securities Note.

 

Chair's statement

I am pleased to announce that, despite the volatile market conditions
witnessed over the last six months, the Company's net asset value increased by
2.1p per share to 57.7p. As described more fully below, the strong performance
of the Company's listed portfolio outweighed the weakness in the value of the
Company's unquoted investments and this once again highlights the benefits of
the Company's investment policy of having a combination of unquoted and listed
assets. This approach supports the Company's aim of providing a more
consistent total return to shareholders over the medium to long term. After
the period end, the NAV has continued to increase through further good
performance of the listed portfolio, as reported on below.

Over the six months to 31 March 2024, whilst the Bank of England base rate
remained at 5.25%, the highest level in 15 years, hostilities in the Middle
East intensified global uncertainty. However, continued reductions in headline
inflation and the stable base rate supported a rebound in UK equity
performance during the latter part of 2023, with markets pricing in
expectations of continued moderating inflation and falling interest rates in
2024. In the first months of 2024, inflation fell by more than many economists
predicted but the benefits were felt unevenly across the UK equity market.
Large cap stocks outperformed their smaller counterparts over the period and
this was partly attributable to investors' lack of confidence in this section
of the market and the further outflows of money from UK funds investing in
smaller cap companies.

As we enter the new quarter, it's fair to say that consumer and business
confidence remain fragile with elevated macroeconomic and geopolitical
uncertainty expected to continue to drive market volatility over the coming
months. However, your Board continues to believe that, in aggregate, the
fundamentals of the underlying portfolio companies remain robust and the
growth prospects for the majority of investee companies continue to be
positive over the medium term.

Results

During the six months to 31 March 2024, the Company's NAV per share increased
3.8 per cent. from 55.6p to 57.7p after the payment of a final dividend of
2.25p per share on 8 March 2024. The table below breaks down the movement in
NAV over the 6 months.

                                                                          Pence per ordinary share

 NAV as at 1 October 2023 (after deducting the final dividend of 2.25p)   55.6
 Valuation increase (3.8 per cent.)                                       2.1
 NAV as at 31 March 2024                                                  57.7

 

The Board is pleased to report as at 31 May 2024, the NAV was 59.8p per share,
a 3.6 per cent. increase over the NAV as at 31 March 2024. This was driven by
firmer quoted markets and further increases in the value of the Company's
listed investments.

Dividends

The Board has declared an interim dividend of 1.75p per share to be paid on 9
September 2024 to shareholders on the register as of 9 August 2024. The Board
is aware that dividends are an important part of the total return to the
shareholders' investment in the Company. As such, the Board is aiming to
achieve its dividend policy objective of an annual yield of 7.0 per cent.
based on the NAV at the beginning of the financial year. I must of course
remind shareholders this is not a guarantee and that payment dates and the
amount of future dividends depend on the level and timing of profitable
realisations.

Portfolio review

The table below provides a summary of each asset class and the return
generated during the period under review.

 Asset class                       NAV (£mn)   % of NAV*  Number of investee companies**  % return in the period***
 Unquoted                          53          25         40                              (4)
 AIM- traded companies             83          38         42                              8
 WS Gresham House UK Equity Funds  68          32         90                              8
 Liquid assets(#)                  11          5          N/A                             3
 Total                             215         100        172                             4

* By value at 31 March 2024.
** Includes investee companies held in more than one fund. Total number of
individual companies held is 159.
*** Return includes interest received on unquoted realisations during the
period.
(#)( )Represents cash, cash liquidity funds and net current assets. % return
in the period relates only to the cash liquidity funds.

The value of the unquoted portfolio decreased 3.8 per cent. in the six months
to 31 March 2024. The drop in value was driven by the reduction in value of
one key asset, with the remaining portfolio showing an increase in value over
the period.

 

The value of the Company's portfolio of investments directly held in
AIM-traded companies increased 8.2 per cent. in the six months to 31 March
2024. The value of the Company's investment into the WS Gresham House UK Micro
Cap Fund ("Micro Cap") increased by 6.7 per cent., the WS Gresham House UK
Smaller Companies Fund increased by 9.2 per cent. and the WS Gresham House UK
Multi Cap Income Fund ("Multi Cap Income") increased by 7.4 per cent. in the
period. This was primarily due to positive news flow from individual companies
across the portfolio being well received by the markets with a number of
trading updates demonstrating better than expected financial performance.

 

In the Manager's regular reporting to the Board, the Directors were pleased to
learn that in the 6 months to 31 March 2024, a number of companies in our
listed portfolio reported in-line or positive news flow in terms of their
financial performance. This is welcome given the economic and political
environment which we are facing.

 

Investments and divestments

 

The Company's investments and divestments during the period are set out below.

 

Investments

 

I am pleased to report that the Company made four new investments totalling
£4.4mn and six follow-on investments with a combined value of £2.9mn in the
six months to 31 March 2024. Below are descriptions of the new investments
made:

 

·      Azarc (unquoted) - Cross‑border customs automation software
provider

 

·      CitySwift (unquoted) - Passenger transport data and scheduling
software provider

 

·      Ozone API (unquoted) - Open banking software developer

 

·      SciLeads (unquoted) - Life Sciences data and lead generation
provider

 

Following the period end, a total of £2.1mn was invested as follows:

 

 * follow-on investment of £0.2mn into Rockfish, a chain of fish restaurants,
which is in our unquoted portfolio

 * follow-on investment of £0.2mn into Yappy, a supplier of customisable pet
products, which is in our unquoted portfolio

 * follow-on investment of £0.5mn into Counting, a banking and software provider
for small businesses, which is in our unquoted portfolio

 * new unquoted investment of £1.2mn into OnSecurity Technology, a penetration
testing provider

 

 

Realisations

During the period, in the unquoted portfolio, Funding Xchange, a SME lending
marketplace, was acquired resulting in a gross money multiple of 0.1x original
cost and Armstrong Craven, a recruitment company, went into administration.
The business had experienced very challenging trading conditions over the past
year and its valuation had already been written down to zero.

In the listed portfolio, Gresham House was acquired via a recommended cash
offer resulting in a gross money multiple of 3.9x original cost. The Manager
also continued to take profits from partial sales of the Company's holding of
Cerillion plc resulting in proceeds of £4.1mn, and a gross money multiple of
21.0x original cost.

Fundraising

I am pleased to report that, shortly after the period end, the Company
successfully raised £25.0mn (before costs) through an offer for subscription
which became fully subscribed in April 2024. The Directors are pleased to
welcome the 800 new shareholders who invested during the offer period and are
appreciative of the continued support of 556 pre-existing shareholders.

The Board will consider whether to raise new funds in the 2024/25 tax year.
This will be determined by the Company's cashflow and its anticipated
requirements to fund new and follow-on investments over the next two to three
years. The Board appreciates that shareholders would like plenty of notice of
its fundraising intentions and will ensure that shareholders are informed of
any such fundraising at the earliest practical time.

Consumer Duty

The FCA's Consumer Duty came into force on 31 July 2023 and, in summary,
requires firms to which this applies to act to deliver good outcomes for their
retail customers. The Consumer Duty regulations apply to the regulated and
ancillary activities of all FCA authorised firms under the Financial Services
and Markets Act 2000, the Payment Services Regulations 2017 and the Electronic
Money Regulations 2011. The Company is not a FCA authorised firm and
accordingly does not fall within scope of these regulations. However, the
Company's Manager, Gresham House Asset Management Ltd, being an FCA authorised
firm, is covered by the regulations and the Board is cognisant of the
Manager's obligations to comply with the Consumer Duty. The Board receives
regular updates from the Manager on the delivery of its obligations under the
Consumer Duty and is satisfied that the Manager is complying with all
appropriate regulation.

 

VCT Regulation - Financial Health Test

 

Since the various VCT rule changes in both 2015 and 2018, VCT qualifying
investments have become focussed on smaller, younger companies. As a result,
when the Manager makes a new investment, they expect to make further follow-on
investments as the investee company progresses and where the business case for
the investment is justified. These follow-on investments are subject to the
same VCT compliance rules as new deals and both rely on certain criteria being
met, including the Financial Health Test.

 

The Financial Health Test is not something new and was primarily introduced as
an anti-abuse regulation. However, following amendment to HMRC's guidance,
there has been an effective tightening of the interpretation the Financial
Health Test. This is resulting in the restriction of potential follow-on VCT
investment to support certain portfolio companies.

 

This has the potential to negatively impact shareholders' returns as a result
of portfolio companies going into administration when they might otherwise
have gone on to be successful. Furthermore, as this is an industry wide issue,
this measure increases the uncertainties small companies face at a
particularly difficult time and may well result in unnecessary job losses and
hardship to employees and their families and has the potential to reduce the
overall tax efficiency of the VCT scheme as a whole.

 

In December 2023, the Venture Capital Trust Association ("VCTA") held a
meeting with government officials to discuss the recent difficulties with the
application of the new guidance. The meeting was successful with the
government officials acknowledging the difficulties. They clarified that going
forward, while the 50% rule (i.e. amount of raised capital converted to
retained losses) will remain the first line of assessment of financial health,
businesses will be given the opportunity to explain why they should be
recognised as financially healthy even if they do not meet this rule.

 

The Board continues to monitor developments in this area carefully and
supports the representations being made by the Association of Investment
Companies ("AIC") and the VCTA to HMRC and HM Treasury.

 

Outlook

The Board expects that elevated macroeconomic and global and domestic
political uncertainty, including anaemic UK economic growth and upcoming
elections in the UK in July and US in November, will continue to drive market
volatility over the coming months. Global investors remain particularly
sensitive to new inflation data and shifting central bank commentary on
interest rates, while conflicts in the Ukraine and the Middle East threaten
regional stability.

 

Against this, the Company's portfolio remains highly diversified and is
largely positioned in sectors which the Manager expects to provide long-term
growth potential. We remain committed to investing through the economic cycle
as experience suggests that this can produce superior returns over the longer
term. This can also provide an opportunity for the Company to make high
quality investments and build strategic stakes in businesses with great
potential at attractive prices. This applies to both new investments and
follow-on investments in the portfolio. The Manager continues to see a good
pipeline of potential investments and the Board is confident that the Company
remains suitably resourced to support investment into new and existing
portfolio companies.

 

 

Sarah Fromson

Chair

10 June 2024

 Investments in the period

 Company                                      Location        Sector                      Activity                                                                        Book    cost   £'000
 Unquoted investments

 New
 Ozone Financial Technology Ltd               London          Technology                  Open banking infrastructure provider                                            1,847
 Huddl Mobility Ltd  (trading as CitySwift)   Ireland         Technology                  SaaS product for bus operators and local authorities to aggregate, cleanse and  938
                                                                                          access insight from data from across their bus networks
 SciLeads Ltd                                 London          Technology                  A data‑intelligence platform that enables companies operating within Life       915
                                                                                          Science verticals to identify, track and convert potential customers
 Azarc.io Inc                                 London          Technology                  Automating customs declarations                                                 652
 Follow-on
 Patchworks Integration Ltd                   London          Technology                  Leading integration platform for fast‑growing retail and ecommerce              910
                                                                                          businesses
 Metrion Biosciences Ltd                      Cambridgeshire  Healthcare & education      Ion channel drug discovery and safety assessment services provider              548
 Focal Point Positioning Ltd                  Cambridgeshire  Technology                  A research and development focused technology business focusing on global       227
                                                                                          navigation and satellite systems
 Orri Ltd                                     London          Healthcare & education      Provider of intensive day care treatments for eating disorders                  114
 Total unquoted investments                                                                                                                                               6,151
 AIM-traded investments
 Follow-on
 Eden Research plc                            Oxfordshire     Business services           Developer of biological fungicides and bio equivalents                          895
 PCI‑PAL plc                                  London          Technology                  Secure payment services provider                                                239
 Total AIM-traded investments                                                                                                                                             1,134
 Total investments in the period(#)                                                                                                                                       7,285

#  Includes unquoted and AIM investments only.

 

 

 

 

 Company                                              First investment date  Original book cost(#) £'000   Proceeds(‡ )     Overall multiple return (x)  IRR (%)

                                                                                                           £'000
 Unquoted realisations
 Funding Xchange Ltd                 Full trade sale  Nov 19                 795                           50               0.1                          0.0
 Armstrong Craven Ltd                Written off      Jun 13                 664                           -                1.1*                         1.6
 Total unquoted realisations                                                 1,459                         50
 AIM-traded realisations
 Cerillion plc                       Market sale      Jul 15                 196                           4,127            21.0                         44.3
 Gresham House plc                   Takeover         Nov 14                 137                           530              3.9                          15.9
 Total AIM - traded realisations                                             333                           4,657
 Total realisations in the period**                                          1,792                         4,707

Realisations in the period

Liquidation proceeds of £114k were received during the period from InterQuest
Group plc, which was written off in September 2023.

(#)  Residual book cost at realisation date.

(‡)  Proceeds at time of realisation including interest.

*  Includes interest/dividends received, loan note redemptions and partial
realisations accounted for in prior periods.

** Includes unquoted and AIM investments only.

Responsibility statement of the Directors in respect of the half-yearly report

Half-yearly report

The important events that have occurred during the period under review, the
key factors influencing the

financial statements and the principal uncertainties for the remaining six
months of the financial year are set out in the Chair's statement and the
Strategic report.

The principal risks facing the Company are unchanged since the date of the
Company's Annual Report for the financial year ended 30 September 2023 and
continue to be as set out in that Report on pages 22 and 23.

Risks faced by the Company include but are not limited to; loss of approval as
a Venture Capital Trust, legislative risk, investment performance risk, risk
of economic, political and other external factors, regulatory and compliance
risk and operational risk. The Board considers the conflicts in Ukraine and
the Middle East to be factors which permeate these risks, and their impacts
for the remaining six months of the year continue to be kept under review.

Responsibility statement

Each director confirms that to the best of their knowledge:

 * the condensed set of financial statements has been prepared in accordance with
FRS 104 Interim Financial Reporting Standards and gives a true and fair view
of the assets, liabilities, financial position and profit or loss of the
Company.

 * This half-yearly report includes a fair review of the information required
by:

a)   DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an
indication of important events that have occurred during the first six months
of the financial year and their impact on the condensed set of financial
statements; and a description of the principal risks and uncertainties for the
remaining six months of the year; and

b)   DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being
related party transactions that have taken place in the first six months of
the current financial year and that have materially affected the financial
position or performance of the Company during that period; and any changes in
the related party transactions described in the last annual report that could
do so.

 

The half-yearly report was approved by the Board of Directors on 10 June 2024
and was signed on its behalf by Ms Sarah Fromson, Chair.

Sarah Fromson

Chair

10 June 2024

Condensed income statement

For the six months to 31 March 2024 (Unaudited)

 

 

                                                                                       Six months to              Six months to              Year to

31 March 2024
31 March 2023
30 September 2023
                                                                                Notes  Revenue  Capital  Total    Revenue  Capital  Total    Revenue  Capital   Total

£'000
£'000
£'000
£'000
£'000
£'000
£'000
£'000
£'000

 Gains/(losses) on investments                                                  5      -        8,029    8,029    -        (2,132)  (2,132)  -        (4,284)   (4,284)
 Income                                                                                2,100    -        2,100    1,201    -        1,201    3,082    -         3,082
 Investment management fee                                                             (593)    (1,779)  (2,372)  (620)    (1,860)  (2,480)  (1,252)  (3,758)   (5,010)
 Other expenses                                                                        (387)    -        (387)    (357)    -        (357)    (700)    -         (700)
 Profit /(loss) before taxation                                                        1,120    6,250    7,370    224      (3,992)  (3,768)  1,130    (8,042)   (6,912)
 Taxation                                                                              -        -        -        -        -        -        -        -         -
 Profit/(loss) for the period, being total comprehensive income for the period         1,120             7,370    224      (3.992)  (3,768)  1,130    (8,042)   (6,912)

                                                                                                6,250
 Return per ordinary share:
                                                                                       0.31p    1.71p    2.02p    0.07p    (1.21p)  (1.14p)

 Basic and Diluted                                                              2                                                            0.33p    (2.32p)   (1.99p)

All items in the above statement derive from continuing operations.

There are no recognised gains and losses other than those disclosed in the
Income Statement.

The revenue column of the Income Statement includes all income and expenses.
The capital column accounts for the realised and unrealised profit or loss on
investments and the proportion of the management fee charged to capital.

The total column of this statement is the unaudited Statement of Total
Comprehensive Income of the Company prepared in accordance with the Financial
Reporting Standard ("FRS"). The supplementary revenue return and capital
return columns are prepared in accordance with the Statement of Recommended
Practice issued by the Association of Investment Companies ("AIC SORP").

 

Condensed statement of changes in equity

 

For the six months to 31 March 2024 (Unaudited)

 

                                                                             Non-distributable reserves                            Distributable reserves
                                                                             Called-up share capital  Share       Revaluation      Capital          Revenue

                                                                             £'000                    premium     reserve          reserve £'000    reserve

                                                                                                       £'000      £'000                             £'000     Total

                                                                                                                                                              £'000
 At 1 October 2023                                                           39,628                   -           23,062           144,092          2,877             209,659
                                                                             -                        -           5,700            550              1,120             7,370

 Profit after taxation
 Net proceeds of share issues, share buybacks & sale of shares from          1,347                    6,666       -                (1, 627)         -         6,386
 treasury
 Dividends paid                                                              -                        -           -                (7,965)          (371)     (8,336)
 Share premium cancellation costs                                            -                        -           -                (4)              -         (4)
 At 31 March 2024                                                            40,975                   6,666       28,762           135,046          3,626     215,075

 

For the six months to 31 March 2023 (Unaudited)

                                                                             Non-distributable reserves                          Distributable reserves
                                                                             Called-up share capital  Share       Revaluation    Capital          Revenue

                                                                             £'000                    premium     reserve        reserve £'000    reserve

                                                                                                       £'000      £'000                           £'000     Total

                                                                                                                                                            £'000
 At 1 October 2022                                                           35,789                   106,099     18,834         49,142           3,122             212,986
                                                                             -                        -           (3,433)        (559)            224               (3,768)

 (Loss)/profit after taxation
 Net proceeds of share issues, share buybacks & sale of shares from          1,933                    10,718      -              (771)            -         11,880
 treasury
 Dividends paid                                                              -                        -           -              (9,116)          (1,013)   (10,129)
 At 31 March 2023                                                            37,722                   116,817     15,401         38,696           2,333     210,969

 

For the year ended 30 September 2023 (Audited)

 

                                                                         Non-distributable reserves                        Distributable reserves         Total

                                                                                                                                                          £'000
                                                                         Called-up share capital  Share       Revaluation  Capital          Revenue

                                                                         £'000                    premium     reserve      reserve £'000    reserve

                                                                                                  £'000       £'000                         £'000
 At 1 October 2022                                                       35,789                   106,099     18,834       49,142           3,122         212,986
 Profit/(loss) after taxation                                            -                        -           4,228        (12,270)         1,130         (6,912)
 Net proceeds of share issues, share buybacks & sale of shares from      3,839                    20,452      -            (2,413)          -             21,878
 treasury
 Dividends paid                                                          -                        -           -            (16,901)         (1,375)       (18,276)
 Cancellation of share premium                                           -                        (126,551)   -            126,551          -             -
 Share premium cancellation costs                                        -                        -           -            (17)             -             (17)
 At 30 September 2023                                                    39,628                   -           23,062       144,092          2,877         209,659

 

Condensed balance sheet

 

As at 31 March 2024 (Unaudited)

 

                                                                      As at           As at

31 March
30 September 2023
                                                   Notes   As at

          2023            £'000
                                                           31 March

          £'000
                                                           2024

                                                           £'000

 Fixed assets
 Unquoted investments                              5       54,585     48,545          50,506
 Traded on AIM                                     5       81,557     77,655          78,973
 Collective investment vehicles                    5       79,077     69,933          80,764
 Investments                                       5       215,219    196,133         210,243

 Current assets
 Debtors                                                   565        1,477           235
 Cash at bank and on deposit                               674        14,803          670
                                                           1,239      16,280          905
 Creditors (amounts falling due within one year)           (1,383)    (1,444)         (1,489)

 Net current (liabilities)/assets                          (144)      14,836          (584)

 Net assets                                                215,075    210,969         209,659

 Capital and reserves
 Called-up share capital                           3       40,975     37,722          39,628
 Share premium                                             6,666      116,817         -
 Capital reserve                                           135,046    38,696          144,092
 Revaluation reserve                               5       28,762     15,401          23,062
 Revenue reserve                                           3,626      2,333           2,877
 Equity shareholders' funds                                215,075    210,969         209,659

 Net asset value per share                                 57.7p      61.0p           57.9p
 Number of ordinary shares in circulation                  372,888,416        345,640,159         362,253,166

 

Condensed statement of cash flows

 

For the six months to 31 March 2024 (Unaudited)

                                                          Six months to  Six months to  Year to

31 March
31 March
30 September

2023

                                                          2024
              2023

              £'000

              £'000
                                                          £'000

 Net cash outflow from operating activities               (1,799)        (2,035)        (3,588)
 Net cash inflow/(outflow) from investing activities      3,775          (21,534)       (35,966)
 Net cash inflow/(outflow) before financing activities    1,976          (23,569)       (39,554)
 Net cash (outflow)/inflow from financing activities      (1,972)        1,750          3,602

 Increase/(decrease) in cash                              4              (21,819)       (35,952)

 Reconciliation of new cash flow to movement in net cash
 Increase/(decrease) in cash                              4              (21,819)       (35,952)
 Opening cash at bank and on deposit                      670            36,622         36,622

 Closing cash at bank and on deposit                      674            14,803         670

 Reconciliation of profit/(loss) before taxation

 to net cash outflow from operating activities
 Profit/(loss) before taxation                            7,370          (3,768)        (6,912)
 (Gains)/losses on investments                            (8,029)        2,132          4,284
 Changes in working capital and other non-cash items      (1,140)        (399)          (960)

 Net cash outflow from operating activities               (1,799)        (2,035)        (3,588)

 

 

Notes to the financial statements

 

For the six months to 31 March 2024 (Unaudited)

 

1. Basis of preparation

 

The condensed financial statements for the six months to 31 March 2024
comprise the unaudited financial statements set out on pages 13 to 16 together
with the related notes on pages 17 to 20. The Company applies FRS 102 and the
AIC SORP for its annual financial statements. The condensed financial
statements for the six months to 31 March 2024 have therefore been prepared in
accordance with FRS 104 'Interim Financial Reporting' and the principles of
the AIC SORP. They have also been prepared on a going concern basis. The
financial statements have been prepared on the same basis as the accounting
policies set out in the Company's Annual Report and Financial Statements for
the year ended 30 September 2023.

The financial information contained in this half‑yearly report does not
constitute statutory accounts as defined in sections 434 - 436 of the
Companies Act 2006. The half‑yearly report for the six months ended
31 March 2024 and for the six months ended 31 March 2023 have been neither
audited nor reviewed by the Company's Auditor. The information for the year to
30 September 2023 has been extracted from the latest published audited
financial statements, which have been filed with the Registrar of Companies.
The report of the Auditor for the audited financial statements for the year to
30 September 2023 was: (i) unqualified; (ii) did not include a reference to
any matters to which the Auditor drew attention by way of emphasis without
qualifying their report; and (iii) did not contain a statement under section
498 (2) or (3) of the Companies Act 2006. No statutory accounts in respect of
any period after 30 September 2023 have been reported on by the Company's
Auditor or delivered to the Registrar of Companies.

 

The Company's half yearly report has been made available on the Company's
website (www.baronsmeadvcts.co.uk (http://www.baronsmeadvcts.co.uk) ) and sent
to shareholders where requested.

 

2.   Performance and shareholder returns

 

Return per share is based on a weighted average of 365,445,232 ordinary shares
in issue (31 March 2023 - 330,678,751 ordinary shares; 30 September 2023 -
346,626,977 ordinary shares).

 

Earnings for the first six months to 31 March 2024 should not be taken as a
guide to the results of the full financial year to 30 September 2024.

 

3.  Called-up share capital

 

The below table details the movement in called-up share capital during the
period.

 

Allotted, called-up and fully paid:

 

 Ordinary shares                                                               £'000
 396,279,533 ordinary shares of 10p each listed at 30 September 2023           39,628
 13,468,470 ordinary shares of 10p each issued during the period               1,347
 409,748,003 ordinary shares of 10p each listed at 31 March 2024               40,975
 34,026,367 ordinary shares of 10p each held in treasury at 30 September 2023  (3,403)
 2,833,220 ordinary shares of 10p each repurchased during the period and held                                           (283)
 in treasury
 36,859,587 ordinary shares of 10p each held in treasury at 31 March 2024      (3,686)
 372,888,416 ordinary shares of 10p each in circulation* at 31 March 2024      37,289
 * Carrying one vote each.

During the six months to 31 March 2024 the Company issued 13,468,470 shares at
net proceeds of £7,957,000 (after costs). During the same period, the Company
purchased 2,833,220 shares to be held in treasury at a cost of £1,571,000
(including costs). The Company sold no shares from treasury. At 31 March 2024,
the Company held 36,859,587 ordinary shares in treasury. Shares may be sold
out of treasury below Net Asset Value as long as the discount at issue is
narrower than the average discount at which the shares were bought into
treasury.

Excluding treasury shares, there were 372,888,416 ordinary shares in
circulation at 31 March 2024 (31 March 2023 - 345,640,159 ordinary shares; 30
September 2023 - 362,253,166 ordinary shares).

4.  Dividends

 

The final dividend for the year ended 30 September 2023 of 2.25p per share
(2.15p capital, 0.10p revenue) was paid on 8 March 2024 to shareholders on
the register on 9 February 2024. The ex-dividend date was 8 February 2024.

 

During the year to 30 September 2023, the Company paid an interim dividend on
8 September 2023 of 2.25p per share (2.15p capital, 0.10p revenue).

 

An interim dividend of 1.75p per share has been declared for the year to 30
September 2024 and is payable on 9 September 2024 to shareholders on the
register as of 9 August 2024. The ex-dividend date is 8 August 2024.

 

5.  Investments

 

All investments are initially recognised and subsequently measured at fair
value. Changes in fair value are recognised in the Income Statement.

The methods of fair value measurement are classified into a hierarchy based on
reliability of the information used to determine the valuation.

 * Level 1 - Fair value is measured based on quoted prices in an active market.

 * Level 2 - Fair value is measured based on directly observable current market
prices or indirectly being derived from market prices.

 * Level 3 - Fair value is measured using a valuation technique that is not based
on data from an observable market.

 

The valuation of unquoted investments contained within level 3 of the Fair
Value hierarchy involves key assumptions dependent upon the valuation
methodology used. The primary methodologies applied are:

·      Cost of recent investment.

·      Earnings multiple.

·      Offer less 10 per cent.

 

The earnings multiple approach involves more subjective inputs than the cost
of recent investment and offer approaches and therefore presents a greater
risk of over or under estimation. Key assumptions for the earnings multiple
approach are the selection of comparable companies and the use of either
historic or forecast revenue or earnings, as considered most appropriate.
Other assumptions include the appropriateness of the discount magnitude
applied for reduced liquidity and other qualitative factors. These assumptions
are described in more detail in note 2.3 in the Company's Report and Financial
Statements for the year to 30 September 2023. The techniques used in the
valuation of unquoted investments have not changed materially since the date
of that report.

                                                     Level 1  Level 2      Level 3
                                                     Traded   Collective              Total

                                                     on AIM   investment              £'000

                                                     £'000    vehicles     Unquoted

                                                              £'000        £'000
 Opening book cost                                   64,431   65,537       57,213     187,181
 Opening unrealised appreciation/(depreciation)      14,542   15,227       (6,707)    23,062
 Opening fair value                                  78,973   80,764       50,506     210,243
 Movements in the year:
 Transfer between levels                             (1,650)  -            1,650            -
 Purchases at cost                                   1,134    11,604       6,151            18,889
 Sale - proceeds                                     (4,657)  (17,120)     (165)            (21,942)
         - realised gains on sales                   759      -            164              923
 Unrealised gains/(losses) realised during the year  3,535    -            (2,129)          1,406
 Increase/(decrease) in unrealised appreciation      3,463    3,829        (1,592)          5,700
 Closing fair value                                  81,557   79,077       54,585           215,219
 Closing book cost                                   63,552   60,021       62,884           186,457
 Closing unrealised appreciation/(depreciation)      18,005   19,056       (8,299)          28,762
 Closing fair value                                  81,557   79,077       54,585           215,219
 Equity shares                                       81,557   -            23,478           105,035
 Preference shares                                   -        -            20,997           20,997
 Loan notes                                          -        -            10,110           10,110
 Collective investment vehicles                      -        79,077       -                79,077
 Closing fair value                                  81,557   79,077       54,585           215,219

 

6.  Other required disclosures

 

6.1 Segmental reporting

 

The Company has one reportable segment being investing in primarily a
portfolio of UK growth businesses, whether unquoted, traded on AIM or
collective investment vehicles.

6.2 Principal risks and uncertainties

The Company's assets consist of equity and fixed interest investments, shares
in collective investment schemes, cash and liquid resources. Its principal
risks are therefore market risk, price risk, credit risk and liquidity risk.
Other risks faced by the Company include loss of approval as a Venture Capital
Trust, legislative, investment performance, economic, political and other
external factors, regulatory and compliance and operational risks. These
risks, and the way in which they are managed, are described in more detail in
the principal risks and uncertainties table within the Strategic report
section in the Company's Annual Report and Financial Statements for the year
ended 30 September 2023. The Board continues to regularly review the risk
environment in which the Company operates.

6.3 Related parties

Gresham House Asset Management Ltd (the "Manager") manages the investments of
the Company. The Manager also provides or procures the provision of
secretarial, accounting, administrative and custodian services to the Company.
Under the management agreement, the Manager receives a fee of 2.5 per cent.
per annum of the net assets of the Company up to and including £209,658,860
(being the total net assets of the Company as at 30 September 2023) and 2.0
per cent. per annum of the amount by which the net assets of the Company
exceed £209,658,860. This is described in more detail under the heading 'The
management agreement' within the Strategic Report in the Company's Annual
Report and Financial Statements for the year ended 30 September 2023. During
the period the Company has incurred management fees of £2,372,000 (31 March
2023 - £2,480,000; 30 September 2023 - £5,010,000) and secretarial and
accounting fees of £89,000 (31 March 2023 - £80,000; 30 September 2023 -
£167,000) payable to the Manager. No performance fee has been accrued at 31
March 2024 (31 March 2023 - £nil; 30 September 2023 - £nil). This is
described in more detail under the heading 'Performance fees' within the
Strategic Report in the Company's Annual Report and Financial Statements for
the year to 30 September 2023.

Under the terms of an Offer for Subscription, launched on 4 December 2023, the
Manager was entitled to fees of 4.50% of the investment amount received from
investors. This amount totalled £693,000, including the amounts allotted in
April 2024, out of which all the costs associated with the allotments were
met.

6.4 Going concern

After making enquiries, and bearing in mind the nature of the Company's
business and assets, the Directors consider that the Company has adequate
resources to continue in operational existence for the foreseeable future. In
arriving at this conclusion, the Directors have considered the Company's cash
balances, the liquidity of the Company's investments and the absence of any
gearing. The Directors are therefore also satisfied that the Company has
adequate financial resources to continue in operation for at least the next 12
months and that, accordingly, it is appropriate to adopt the going concern
basis in preparing the financial statements.

 

6.5 Post balance sheet events

The following events occurred between the balance sheet date and the signing
of these financial statements:

 * The 30 April 2024 NAV of 58.6p was announced on 7 May 2024 and the 31 May 2024
NAV of 59.8p was announced on 6 June 2024. At the date of publishing this
report, the Board is unaware of any matter that will have caused the NAV per
share to have changed significantly since the latest NAV.

 * Purchased 0.6mn Ordinary Shares of 10.0p on 2 April 2024 at a price of 55.2p
per share to be held in Treasury.

 * Purchased 1.4mn Ordinary Shares of 10.0p on 24 May 2024 at a price of 55.6p
per share to be held in Treasury.

 * 27.7mn shares were issued on 3 April 2024 at allotment prices between 59.7p
and 62.6p under the current Offer.

 * One new investment, into OnSecurity Technology, completed in June 2024
totalling £1.2mn.

 * Three follow-on investments, into Yappy, Rockfish and Counting, completed
between April to May 2024, totalling £1.0mn.

 * Partial realisations in Cerillion were made in May 2024, realising proceeds of
£1.8mn and making a return of 21.0x cost.

 * Realised Gama Aviation in May 2024, receiving proceeds of £0.6mn and making a
return of 0.6x cost.

 

 

 Directors                            Brokers

 Sarah Fromson (Chair)†               Panmure Gordon & Co(‡)

 Malcolm Groat*                       40 Gracechurch Street

 Graham McDonald                      London EC3V 0BT

 Tim Farazmand(#)                     Tel: 020 7886 2500

 Secretary                            Auditor

 Gresham House Asset Management Ltd   BDO LLP

                                      55 Baker Street

 Registered Office                    London W1U 7EU

 5 New Street Square

 London EC4A 3TW                      Solicitors

                                      Howard Kennedy LLP

 Investment Manager                   1 London Bridge

 Gresham House Asset Management Ltd   London SE1 9BG

 5 New Street Square

 London EC4A 3TW                      VCT Status Adviser

 Tel: 020 7382 0999                   PricewaterhouseCoopers LLP

                                      1 Embankment Place

 Registered Number                    London WC2N 6RH

 04115341

                                      Website

 Registrars and Transfer Office       www.baronsmeadvcts.co.uk (http://www.baronsmeadvcts.co.uk/)

 The City Partnership (UK) Ltd

 The Mending Rooms

 Park Valley Mills

 Meltham Road

 Huddersfeld HD4 7BH

 Tel: 01484 240 910

Corporate information

(†) Chair of the Nomination Committee.

(*) Senior Independent Director and Chair of the Audit & Risk Committee.

(#) Chair of the Management Engagement and Remuneration Committee.

(‡) Merger between Liberum and Panmure Gordon completed May 2024.

 

LEI: 2138008D3WUMF6TW8C28

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR GPUGAQUPCPGU

Recent news on Baronsmead Second Venture Trust

See all news